Page 2905 - Cote clinical veterinary advisor dogs and cats 4th
P. 2905

1552  Boldface page numbers indicate chapter titles. Page numbers followed by a indicate algorithms; b, boxes; e, electronic content; f, figures; and t, tables.


           Plavix. See Clopidogrel            Polydipsia (Continued)             Posaconazole
           Play dough, salt toxicosis and, 900.e2–900.e3  differential diagnosis of, 1271  for cryptococcosis, 225
                                                                                   for fungal infections, 373
                                               phenobarbital and, 783.e3
           PLE. See Protein-losing enteropathy (PLE)
  VetBooks.ir  Pleocytosis, 1323              Polyethylene glycol-electrolyte solution. See GoLYTELY  Positive pressure ventilation (PPV), 1185–1187, 1187f
                                                                                   for opportunistic fungal infections, 373
           Plerixafor, 1499
                                              Polyflex. See Ampicillin
                                                                                 Positron emission tomography (PET) scan,
           Pleural disorders, and dyspnea, 1219
                                              Polymorphonuclear neutrophil (PMN). See Neutrophil(s)
           Pleural effusion, 791–793, 1269
                                                                                    1151.e3–1151.e4
            mesothelioma and, 651             Polymyositis                       Post-traumatic stress disorder, canine, 744–745
                                               description of, 320
            milky white, Mesocestoides as cause of, 650.e2  immune-mediated, 807.e2  Posterior uveitis. See Uveitis
           Pleural empyema. See Pyothorax     Polyneuropathy, 808–809            Postgrooming folliculitis/furunculosis, 852
           Pleural hemorrhage. See Hemothorax  Polyp                             Posthitis, 780.e2
           Pleural shock, 792                  gastric, 379                      Postpartum management of bitch/queen, 1151–1153
           Pleural tap. See Thoracocentesis    nasopharyngeal, 681–683, 683.e1f  Postpartum metrorrhagia, 950
           Pleurodesis, 173                    stridor/stertor and, 945          Postpartum placentitis, 950
           Pleuroperitoneal drainage, 173     Polyphagia, 809–810, 1270–1271     Postparturient disorders
           Pleuroperitoneal hernia. See Diaphragmatic hernia  Polypnea. See Panting  lactation disorders, 570–571
           PLI. See Pancreatic lipase immunoreactivity (PLI)  Polyradiculoneuritis, 810–812  subinvolution of placental sites, 950–951, 951f,
           PLN. See Protein-losing nephropathy (PLN)  Polysialia, 833                 951.e1f
           Plumbism. See Lead, toxicosis      Polysulfated glycosaminoglycan. See   Postrabies vaccination panniculitis and alopecia, 47, 47f
           PMN (polymorphonuclear neutrophil). See Neutrophil(s)  Glycosaminoglycan-polysulfated  Postrenal azotemia, 1201.e3
           PMSG. See Pregnant mare serum gonadotropin    Polyurethane adhesive toxicosis, 32–33  Postural reflexes, 1136–1137
             (PMSG)                           Polyuria, 812–814                  Postwhelping care. See Postpartum management of bitch
           Pneumocystosis, 793.e2–793.e3       diabetes mellitus and, 252        Pot (marijuana), 625
           Pneumomediastinum, 640–642          diagnostic approach to, 1442a     Potassium
           Pneumonia                           differential diagnosis of, 1271     for gastric dilation/volvulus, 378
            aspiration, 793–794                phenobarbital and, 783.e3           serum levels of, 1374–1375
             management of, 1440a             Pomeranian                            decreased. See Hypokalemia
             predisposing conditions, 1269     alopecia X in, 44–45, 44f            increased. See Hyperkalemia
            bacterial, 795–797, 796f, 1134     atlantoaxial subluxation in, 88     supplementation of, for hyperaldosteronism, 491.e2
            bacterial isolates from, 1202.e1   black skin disease in, 44         Potassium bromide
            cryptogenic organizing, 553        collapsing trachea in, 194          administration and dosage of, 1499
            endogenous lipid, 553              Eisenmenger’s syndrome in, 288.e2   drug interactions, 1510.e1t–1510.e5t
            eosinophilic, 553                  hydrocephalus in, 481               for epilepsy, idiopathic, 303
            and lung abscess, 5                neck pain in, 683                   laboratory analysis of, 1319
            lymphocytic interstitial, 553      nephrolithiasis in, 689             seizure disorders and, 1319
            Pneumocystis carinii. See Pneumocystosis  patent ductus arteriosus in, 764  Potassium chloride
            smoke inhalation and, 920          persistent deciduous teeth in, 238  for albuterol toxicosis, 43
           Pneumonitis                         urolithiasis in, 1014, 1014.e2      for hypokalemia, 517, 517t
            aspiration. See Pneumonia, aspiration  Pompe disease, 945.e2–945.e3  Potassium citrate
            feline. See Chlamydiosis          Ponazuril, 187, 1499                 administration and dosage of, 1499
           Pneumonyssoides caninum, 680.e2, 887  Pondocillin. See Pivampicillin    for oxalate urolithiasis, 1015
           Pneumothorax, 797–798, 798.e1f     Pont Audemer spaniel dog, follicular dysplasia in, 344  for renal tubular acidosis, 879.e3
           PO 2, 1065.e1–1065.e2              Poodle. See also Miniature poodle; Standard poodle; Toy   for urate/biurate urolithiasis, 1020
           Pocket depth, 776–777                 poodle                          Potassium gluconate, 517
           Pocket wounds, cat bite abscess and, 5  black, claw disorders in, 179   administration and dosage of, 1499
           Pododemodicosis, 245f               eyelid masses in, 318               for Fanconi syndrome, 323
           Pododermatitis, 799–800, 799f       hyperadrenocorticism in, 485        for hypokalemic myopathy, 676.e2
            plasma cell, 350, 351f             hypoadrenocorticism in, 513       Potassium iodide, 938
           Poikilocytes, 1374–1375             hypothyroidism in, 525            Potassium peroxymonosulfate, for chlamydiosis,
           Poikilocytosis, 1381                immune-mediated thrombocytopenia in, 972  158–159
           Pointer. See also English pointer   inguinal hernia in, 549           Potassium phosphate, 1499
            caudal myopathy in, 149.e2         intestinal adenocarcinoma in, 30    for albuterol toxicosis, 43
            entropion in, 296                  lymphoma in, 609                  Potpourri toxicosis, 816.e2–816.e3
            juvenile cellulitis in, 848        mammary gland neoplasia in, 623   PPA. See Phenylpropanolamine (PPA)
            mammary gland neoplasia in, 623    mitral/tricuspid regurgitation in, 658  PPV. See Positive pressure ventilation (PPV)
            myoclonic epilepsy in, 661         myoclonic epilepsy in, 661        PRA. See Progressive retinal atrophy (PRA)
            pannus in, 748                     osteogenesis imperfecta in, 724.e2  Pradofloxacin, 143.e4, 439
            pseudocyesis in, 831               paraphimosis in, 756.e4             characteristics of, 1499
            stunted growth in, 946             postrabies vaccination panniculitis and alopecia in, 47  drug interactions, 1510.e1t–1510.e5t
            umbilical hernia in, 1003          pyloric outflow obstruction in, 851.e2  for hepatobiliary infections and abscesses, 456
           Poisoning, 800–801. See also Toxicosis  pyoderma in, 851              Pralidoxime chloride
           Polioencephalomyelitis, inclusion body, 271  rectal masses in, 865      administration and dosage of, 1200t–1201t, 1499
           Poliosis, 195                       retinal degeneration in, 883        for organophosphate toxicosis, 719
           Pollakiuria, 802–803, 1270          salivary gland disorders in, 894  Praziquantel
           Polyarteritis, juvenile, 568.e2–568.e3. See also Steroid-  vasculitis in, 1031.e4  administration and dosage of, 1499
             responsive meningitis-arteritis   von Willebrand disease in, 1043     for echinococcosis, 281.e1
           Polyarthritis, 803–805             Popeye sign, 377                     for giardiasis, 387
            bacteria that cause, 1202.e1      Porcine growth hormone, for pituitary dwarfism, 790.e2  for lung parasites, 596
            classification of, 1270           Porcupine quills, 354.e2, 1151.e9–1151.e10  for Mesocestoides infection, 650.e2
            diagnosis of, 1441a               Portal hypertension, cirrhotic/fibrosing liver disease and,   for salmon poisoning, 898
            feline chronic progressive, 888      174                               for schistosomiasis, 901.e3
            immune-mediated erosive. See Rheumatoid arthritis  Portal vein hypoplasia. See Hepatic microvascular   for sparganosis, 928.e3
            treatment of, 1441a                  dysplasia                       Prazosin
           Polychromatophilic erythrocytes. See Reticulocytes  Portal vein thrombosis, 814.e2–814.e3  administration and dosage of, 1499
           Polyclonal gammopathy, 1376        Portocaval shunt. See Portosystemic shunt  for feline lower urinary tract signs, 333t
           Polycystic kidney disease (PKD), 805–806, 806.e1f  Portosystemic shunt, 814–816, 1271  for reflex dyssynergia, 872
            renomegaly and, 879.e4             stunted growth and, 946–947         for urinary bladder atony/hypotonia, 90
           Polycythemia. See also Erythrocytosis  Portosystemic vascular anomaly. See Portosystemic shunt  PRCA. See Pure red cell aplasia (PRCA)
            erythrocytosis and, 1337          Portuguese podenco, cerebellar cortical degeneration in,   Pre-emptive analgesia, 735
            in hyperviscosity syndrome, 509–511  149.e3                          Precaval syndrome. See Cranial vena cava (CrVC)
           Polycythemia rubra vera. See Polycythemia vera  Portuguese water dog     syndrome
           Polycythemia vera, 588, 806–807, 1432a  dermatomyositis in, 246.e2    Preclinical chronic kidney disease. See Chronic kidney
           Polydipsia, 812–814                 dilated cardiomyopathy in, 263       disease, occult (asymptomatic)
            diabetes mellitus and, 252         follicular dysplasia in, 344, 344f  Precose. See Acarbose
            diagnostic approach to, 1442a      hypoadrenocorticism in, 513       Prednisolone sodium succinate, 1499
                                                     www.ExpertConsult.com
   2900   2901   2902   2903   2904   2905   2906   2907   2908   2909   2910